Last reviewed · How we verify
NCT06289816
Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes
trial testing Minimally Invasive Surgery in Spleen-Preserving Surgery in 18 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | Yarmouk University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18 |
| Start date | 1 January 2015 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- Minimally Invasive Surgery
Conditions studied
- Spleen-Preserving Surgery — all drugs for Spleen-Preserving Surgery →
- Echinococcus Granulosus Infection — all drugs for Echinococcus Granulosus Infection →
- Hydatid Disease — all drugs for Hydatid Disease →
- Minimally Invasive Surgery — all drugs for Minimally Invasive Surgery →
Sponsor
Yarmouk University
Who can join
Adults 18 to 70, any sex, with Spleen-Preserving Surgery or Echinococcus Granulosus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective cohort study examines the effectiveness of minimally invasive spleen-preserving surgeries compared to total splenectomy for treating primary splenic hydatidosis in Jordan. Covering 18 patients from January 2015 to June 2021, the research highlights similar recurrence rates between both surgical approaches, emphasizing the benefits of spleen preservation in maintaining immune function and reducing septic risks, particularly in pediatric patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Minimally invasive spleen-preserving surgery to treat primary splenic hydatidosis: short and long-term outcomes: a cohort study.
Aljaiuossi A, Ba-Shammakh SA, Bani Hani M, Al-A'athal MS, et al · · 2024 · cited 2× · PMID 39238958 · DOI 10.1097/ms9.0000000000002320
Verify or expand the search:
- PubMed search for NCT06289816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Minimally Invasive Surgery
Trials testing the same drug.
- NCT05646316 — Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer · Phase 3 · recruiting
- NCT06753656 — Comparison of Patients Who Underwent Open and Minimally Invasive Fixation in Lateral Malleolar Fractures · NA · completed
- NCT04575935 — Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal · Phase 3 · recruiting
Other Yarmouk University trials
Trials by the same sponsor.
- NCT07294599 — Morning Versus Evening Patching in Childhood Amblyopia · NA · not yet recruiting
- NCT06766227 — Smoking Cessation App. in Arabic · NA · not yet recruiting
- NCT04650035 — The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak · completed
- NCT05106803 — Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06289816 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yarmouk University
- Last refreshed: 4 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06289816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing